Market Cap : 6.88 M | Enterprise Value : 6.75 M | P/E (TTM) : | P/B : |
---|
OTCPK:ICOTF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OTCPK:ICOTF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. iCo Therapeutics's Total Debt Per Share for the quarter that ended in Sep. 2020 was $0.00.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
iCo Therapeutics's Total Debt Per Share for the fiscal year that ended in Dec. 2019 is calculated as:
Total Debt Per Share | = | (Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation) | / | Shares Outstanding (EOP) |
= | (0.00 | + | 0.00) | / | 153.75 | |
= | 0.00 |
iCo Therapeutics's Total Debt Per Share for the quarter that ended in Sep. 2020 is calculated as:
Total Debt Per Share | = | (Long-Term Debt & Capital Lease Obligation | + | Short-Term Debt & Capital Lease Obligation) | / | Shares Outstanding (EOP) |
= | (0.00 | + | 0.00) | / | 153.75 | |
= | 0.00 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline